Xenetic Biosciences Inc (XBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,500 | 2,540 | 1,707 | 1,161 | 437 |
| Gross Profit | 2,500 | 2,540 | 1,707 | 1,161 | 437 |
| Operating Expenses | 6,705 | 7,056 | 8,425 | 6,908 | 14,375 |
| Operating Income | -4,204 | -4,516 | -6,718 | -5,747 | -13,938 |
| Other Income | 244 | 381 | 166 | 102 | 126 |
| Pre-tax Income | -3,960 | -4,135 | -6,552 | -5,645 | -13,812 |
| Income Tax | N/A | N/A | N/A | N/A | -2,919 |
| Net Income Continuous | -3,960 | -4,135 | -6,552 | -5,645 | -10,894 |
| Net Income | $-3,960 | $-4,135 | $-6,552 | $-5,645 | $-10,894 |
| EPS Basic Total Ops | -2.57 | -2.71 | -4.61 | -5.50 | -17.00 |
| EPS Basic Continuous Ops | -2.57 | -2.71 | -4.61 | -5.49 | -17.04 |
| EPS Diluted Total Ops | -2.57 | -2.71 | -4.61 | -5.50 | -17.00 |
| EPS Diluted Continuous Ops | -2.57 | -2.71 | -4.61 | -5.49 | -17.04 |
| EPS Diluted Before Non-Recurring Items | -2.57 | -2.71 | -4.60 | N/A | -2.30 |
| EBITDA(a) | $-4,204 | $-4,516 | $-6,691 | $-5,711 | $-13,909 |